Errors and optimization of management of patients with chronic lumbalgia: Discussion based on the clinical observation
https://doi.org/10.21518/ms2024-472
Abstract
Chronic nonspecific low back pain (chronic lumbalgia) is one of the most common causes of disability in the adult population. Currently, effectivemethods of treatment of chronic nonspecific lumbalgia have been proposed, which include an educational program, kinesiotherapy, psychologicalmethods of treatment and optimization of drugtherapy. However, these methods are not often used in real clinical practice, which reflects the observation of a 52-year-old patient who had no positive effect from therapy for 6 months. According to the MRI data, the patient had herniated discs at the level of the lower lumbar discs, with which the patient associated a persistent pain effect. However, the examination revealed signs of damage to the facet joints and sacroiliac joint, which were of leading importance as an anatomical cause of pain. The patient also had emotional disorders, the phenomenon of catastrophization, and painful behavior. An educational conversation was held with the patient, therapeutic exercises were selected, Novema in the afternoon and Novema Night in the evening were prescribed as a non-steroidal anti-inflammatory drug. After 7 days, the pain decreased significantly, sleep improved, adherence to therapeutic gymnastics increased, after 1.5 months the pain syndrome regressed, the patient became active as before the disease. The issues of optimizing the management of patients with chronic lumbalgia and the possibility of widespread implementation of an integrated approach in clinical practice are discussed.
About the Authors
A. Kh. Mukhametzyanova
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Albina Kh. Mukhametzyanova - Neurologist, Postgraduate Student of the Department of Nervous Diseases and Neurosurgery, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University).
11, Bldg. 1, Rossolimo St., Moscow, 119021
V. A. Parfenov
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Vladimir A. Parfenov - Dr. Sci. (Med.), Professor, Neurologist, Head of the Department of Nervous Diseases and Neurosurgery, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University).
11, Bldg. 1, Rossolimo St., Moscow, 119021
References
1. GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(6):e316–e329. https://doi.org/10.1016/S2665-9913(23)00098-X.
2. Itz CJ, Geurts JW, van Kleef M, Nelemans P. Clinical course of non-speci c low back pain: a systematic review of prospective cohort studies set in primary care. Eur J Pain. 2013;17(1):5–15. https://doi.org/10.1002/j.1532-2149.2012.00170.x.
3. Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478–491. https://doi.org/10.7326/0003-4819-147-7-200710020-00006.
4. Tavee JO, Levin KH. Low back pain. Continuum. 2017;23(2):467–486. https://doi.org/10.1212/CON.0000000000000449.
5. Bernstein IA, Malik Q, Carville S, Ward S. Low back pain and sciatica: summary of NICE guidance. BMJ. 2017;356:i6748. https://doi.org/10.1136/bmj.i6748.
6. Maher C, Underwood M, Buchbinder R. Non-specifc low back pain. Lancet. 2017;389(10070):736–747. https://doi.org/10.1016/s0140-6736(16)30970-9.
7. Oliveira CB, Maher CG, Pinto RZ, Traeger AC, Lin CC, Chenot JF et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27(11):2791–2803. https://doi.org/10.1007/s00586-018-5673-2.
8. Парфенов ВА, Исайкин АИ. Боли в нижней части спины: мифы и реальность. М.: ИМА-ПРЕСС; 2016. 104 с. Режим доступа: https://nnp.imapress.net/nnp/article/view/842/.
9. Koes BW, van Tulder M, Lin CW, Macedo LG, McAuley J, Maher C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;19:2075–2094. https://doi.org/10.1007/s00586-010-1502-y.
10. Golovacheva VA, Golovacheva AA, Tarshilova AR. Chronic musculoskeletal low back pain: mistakes in patient management and optimization issues. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(3):103–109. (In Russ.) https://doi.org/10.14412/2074-2711-2024-3-103-109.
11. Brinjikji W, Luetmer PH, Comstock B, Bresnahan BW, Chen LE, Deyo RA et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol. 2015;36(4):811–816. https://doi.org/10.3174/ajnr.a4173.
12. Chiu CC, Chuang TY, Chang KH, Wu CH, Lin PW, Hsu WY. The probability of spontaneous regression of lumbar herniated disc: a systematic review. Clin Rehabil. 2015;29(2):184–195. https://doi.org/10.1177/0269215514540919.
13. Chenot J-F, Greitemann B, Kladny B, Petzke F, Pfingsten M, Schorr SG. Non-Specific Low Back Pain. Dtsch Arztebl Int. 2017;114(51-52):883–890. https://doi.org/10.3238/arztebl.2017.0883.
14. Suslova EJu, Parfenov VA. A complex approach to the treatment of patients with chronic lumbalgia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2015;115(10-2):16–21. (In Russ.) https://doi.org/10.17116/jnevro201511510216-21.
15. Golovacheva VA, Golovacheva AA. Successful combinations of drug and non-drug therapy for low back pain. Russian Journal of Pain. 2024;22(1):57–67. (In Russ.) https://doi.org/10.17116/pain20242201157.
16. Golovacheva VA, Tabeeva GR, Golovacheva AA. Non-specific low back pain: principles and algorithms for successful management of patients in real clinical practice. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(3):85–94. (In Russ.) https://doi.org/10.14412/2074-2711-2023-3-85-94.
17. Isaikin AI, Nasonova TI, Mukhametzyanova AKh. Emotional disorders and their therapy in chronic low back pain. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(5):90–95. (In Russ.) https://doi.org/10.14412/2074-2711-2022-5-90-95.
18. Ho EK, Chen L, Simic M, Ashton-James CE, Comachio J, Wang DXM et al. Psychological interventions for chronic, non-specific low back pain: systematic review with network meta-analysis. BMJ. 2022;376:e067718. https://doi.org/10.1136/bmj-2021-067718.
19. Wong JJ, CôtéP, Sutton DA, Randhawa K, Yu H, Varatharajan S et al. Clinical practice guidelines for the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur J Pain. 2016;21(2):201–216. https://doi.org/10.1002/ejp.931.
20. Hooten WM, Cohen SP. Evaluation and Treatment of Low Back Pain: A Clinically Focused Review for Primary Care Specialists. Mayo Clin Proc. 2015;90(12):1699–1718. https://doi.org/10.1016/j.mayocp.2015.10.009.
21. Parfenov VA, Yakhno NN, Davydov OS, Kukushkin ML, Churyukanov MV, Golovacheva VA et al. Chronic nonspecific (musculoskeletal) low back pain. Guidelines of the Russian Society for the Study of Pain (RSSP). Neurology, Neuropsychiatry, Psychosomatics. 2019;11(2S):7–16. (In Russ.) https://doi.org/10.14412/2074-2711-2019-2S-7-16.
22. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A. 1994;91(25):12013–12017. https://doi.org/10.1073/pnas.91.25.12013.
23. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. 2000;284(10):1247–1255. https://doi.org/10.1001/jama.284.10.1247.
24. Migliorini F, Vaishya R, Pappalardo G, Schneider M, Bell A, Maffulli N. Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain. BMC Musculoskelet Disord. 2023;24(1):432. https://doi.org/10.1186/s12891-023-06537-0.
25. Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008;2008(1):CD000396. https://doi.org/10.1002/14651858.cd000396.pub3.
26. Nasonov EL, Yakhno NN, Karateev AE, Alekseeva LI, Barinov AN, Barulin AE et al. General principles of treatment for musculoskeletal pain: interdisciplinary consensus. Rheumatology Science and Practice. 2016;54(3):247–265. (In Russ.) Available at: https://rsp.mediar-press.net/rsp/article/view/2206.
27. Karateev AE, Nasonov EL, Ivashkin VT, Martynov AI, Yakhno NN, Arutyunov GP et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Rheumatology Science and Practice. 2018;56(Suppl. 1):1–29. (In Russ.) Available at: https://rsp.mediar-press.net/rsp/article/view/2536/1691.
28. Levin OS, Skoromets AA, Tabeeva GR, Doronina OB, Shirokov VA, Trinitatsky YuV et al. The efficacy and safety of naproxen in the treatment of nonspecific lumbalgia: the results of an open multi-center study (NEST). Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019;119(5):27–31. (In Russ.) https://doi.org/10.17116/jnevro201911905127.
29. Karateev AE. Naproxen: A universal analgesic with a minimal risk of cardiovascular events. Sovremennaya Revmatologiya. 2016;10(2):70–77. (In Russ.) https://doi.org/10.14412/1996-7012-2016-2-70-77.
30. Cooper S, Laurora I, Wang Y, Venkataraman P, An R, Roth T. Efficacy and tolerability studies evaluating a sleep aid and analgesic combination of naproxen sodium and diphenhydramine in the dental impaction pain model in subjects with induced transient insomnia. Int J Clin Pract. 2015;69(10):1149–1158. https://doi.org/10.1111/ijcp.12669.
31. Danilov AB, Pilipovich AA, Pyastolova MV. NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational study. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(6):56–63. (In Russ.) https://doi.org/10.14412/2074-2711-2023-6-56-63.
Review
For citations:
Mukhametzyanova AK, Parfenov VA. Errors and optimization of management of patients with chronic lumbalgia: Discussion based on the clinical observation. Meditsinskiy sovet = Medical Council. 2024;(22):47-52. (In Russ.) https://doi.org/10.21518/ms2024-472
Views:
156
Email this article 